I recently reviewed a paper for a journal and my recommendation was “accept with minor modifications”, whereby my suggestions for improvement were provided to the authors – as is usual. Eventually, the paper was resubmitted – my suggestions were implemented and I recommended “accept.” But I noticed that the other reviewer had recommended reject with no comments to the authors other than saying it was an article of limited interest. As a sometimes author I would have been pretty unhappy with such sparse feedback. I think authors deserve better.
These requests are not coming from Clinical Chemistry or similar journals. In the last two weeks, here is a list of journals requesting me to submit an article. Many (all?) require fees to publish your article.
Journal of Clinical Research and Ophthalmology
Open Access Journal of Diabetes
Endocrinological diabetes Clinical and Medical Research
Archives of Preventive Medicine
International Journal of Diabetes and Clinical Research
EC Diabetes and Metabolic Research
Journal of International Medical Research
European Journal of Biomedical and Pharmaceutical Sciences
Functional Foods in Health and Disease Journal
International Journal of Engineering Inventions
Journal of Palliative Care
Advances in Mechanical Engineering
Journal Cell Biology & Cell Metabolism
International Journal of Sports and Exercise Medicine
Therapeutic Advances in Endocrinology and Metabolism
International Journal of Computational Engneering Research
Journal of Research in Diabetes & Metabolism
When I was in industry, we would have a “release for sale” meeting in order to determine whether the product should be released or not. The person from regulatory affairs was always irksome because he always insisted the product was not ready for release. Yet, two hours or so later he signed the release for sale form. I think he behaved this way to show that 1) he was not some guy who would rubber stamp anything that was put in front of him and 2) if there were product problems he could say, he never wanted to release the product. But he nevertheless always looked bad because basically no new data had been put in front of him, yet he signed the release for sale form without someone putting a gun to his head. If he truly believed the product was not ready, he should have stuck to his guns.
But back to the title…, as a “concession” the marketing guy would say, ok let’s have a limited release for sale implying that fewer units would be delivered than possible. Of course, this was fiction – what the limited release really meant was marketing was limited to selling units as fast as they could, and because of startup issues, product sales usually took some time to get going.
On a more positive note, our release for sale meetings – as I recall – were always unanimous, and not every time was the decision to release – sometimes it was decided to not release the product.